Stack analysis
Resveratrol + quercetin + fisetin
Polyphenol ‘longevity / senolytic-adjacent’ influencer stacks.
Confidence
52/100
Registry ingredients
Structured entries from our supplement intelligence registry (not personalized recommendations).
- Resveratrolcompound
Evidence tier: low·Typical label range: Studies wide range; bioavailability low without formulations.
- Quercetincompound
Evidence tier: medium·Typical label range: Often 500-1000 mg/day with enhancers; poorly soluble.
- Fisetincompound
Evidence tier: low·Typical label range: Human senolytic trials ongoing; supplement megadosing not equivalent.
What this stack claims
Autophagy, senescent cell clearance, inflammation reduction - claims often leap from rodents to humans.
Biological logic
Polyphenols hit many pathways in cells; human bioavailability and effect sizes are limiting factors.
Evidence level
Registry tier for this stack: LOW
Human senolytic protocols that resemble influencer stacks are not established as safe DIY regimens. Fisetin human trials are not equivalent to bottle dosing.
Risks
Drug interactions (CYP/P-gp), bleeding additive risk, wasted money, distraction from proven prevention (exercise, sleep, cardiometabolic care).
Final verdict
**Research-curious territory, retail-overhyped** for general users - do not treat as an anti-aging protocol.
FAQ
- Is this the same as clinical senolytics?
- No. Clinical trials use protocols, monitoring, and often prescription drugs - not three bottles from an affiliate link.
- Any serious interaction risks?
- Yes - especially with anticoagulants and narrow therapeutic index drugs; pharmacist review is warranted.
- Better than diet polyphenols?
- Whole-food patterns have broader support than concentrated stacks for population health - not as sexy, more evidence-dense.